Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

  • This share is currently suspended. It was suspended at a price of 398.00
  • There is currently no data for TYMN

Trading Statement

16 Nov 2023 07:00

RNS Number : 5981T
Tyman PLC
16 November 2023
 

TYMAN PLC

Trading Update

Tyman plc ("Tyman" or the "Group"), a leading international supplier of engineered fenestration components and access solutions to the construction industry, provides an update on trading for the period from 1 January 2023 to 31 October 2023 ("the period").

Current trading and outlook

The Board expects full year adjusted operating profit to be in line with market expectations*, despite continued challenging market conditions.

Group revenue decreased by 9% to £557.0 million on a reported basis and by 10% on a like-for-like ("LFL") basis for the ten months to 31 October 2023 compared with the corresponding period in 2022. The decrease in LFL revenue reflects continued weakness in volumes, which more than offset the benefit of the carryover of prior year pricing actions. The agility of our teams in managing cost, together with the reversal of the pricing lag, has limited the decline in adjusted operating profit.

Notably, the North American division is making solid progress expanding its operating margin. The division is also benefitting from the acquisition of Lawrence Industries which was acquired in July; the integration is progressing well, and the business is performing in line with our expectations at the time of acquisition.

During the second half, Tyman has progressed with its previously announced initiatives to structurally improve the cost base whilst also implementing further measures, including the announcement of the closure of its loss-making business in China. The Group will continue to review its cost base to ensure it has the flexibility to swiftly adapt to any potential changes in demand.

The Group's cash generation remains strong, reflecting a significant reduction in inventory in the period, and leverage is expected to be in the middle of the target range of 1.0-1.5x by year end.

Jason Ashton, Interim Chief Executive Officer, commented:

"The Group has delivered a solid trading performance despite the challenging market conditions and, consequently, we expect full year adjusted operating profit to be in line with market expectations*.

We remain confident in the positive structural industry growth drivers across the Group's markets, most notably in the US, as highlighted in our recent capital markets event. Our continued focus on taking market share and enhancing our operational platform ensures that Tyman is well positioned for growth when the US housing market backdrop improves, building on our portfolio of highly engineered, differentiated products, market-leading brands, deep customer relationships and sustainability credentials."

16 November 2023

Enquiries

Tyman plc (investor.relations@tymanplc.com, 0207 9768000)

Jason Ashton - Interim Chief Executive Officer

Juliette Lowes - Interim Chief Financial Officer

Matt Jones - Head of Investor Relations

 

 

MHP (tyman@mhpgroup.com, 07801 894577)

Reg Hoare / Rachel Farrington / Matthew Taylor

Notes to editors

Tyman (TYMN: LSE) is a leading international supplier of engineered fenestration components and access solutions to the construction industry. The company designs and manufactures products that enhance the comfort, sustainability, security, safety and aesthetics of residential homes and commercial buildings. Tyman's portfolio of leading brands serves its markets through three divisions: Tyman North America, Tyman UK and Ireland and Tyman International. Headquartered in London, the Group employs approximately 3,400 people with facilities in 16 countries worldwide. Further information is available at www.tymanplc.com.

*Company compiled analyst consensus of £83.6 million, with a range of £82.8 million - £84.3 million. Details can be found at: https://www.tymanplc.com/investor-relations/analysts-consensus.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUBDBXUBDGXU
Date   Source Headline
5th Oct 20225:01 pmRNSHolding(s) in Company
5th Oct 20225:00 pmRNSHolding(s) in Company
5th Oct 20224:04 pmRNSHolding(s) in Company
19th Aug 20223:33 pmRNSHolding(s) in Company
1st Aug 20223:34 pmRNSHolding(s) in Company
26th Jul 20227:00 amRNSHalf-year Report
17th Jun 20224:23 pmRNSHolding(s) in Company
6th Jun 20228:08 amRNSDirector/PDMR Shareholding
24th May 20229:57 amRNSDirector/PDMR Shareholding
19th May 20224:41 pmRNSDirector/PDMR Shareholding
19th May 20224:40 pmRNSResult of AGM
19th May 20227:00 amRNSAGM Trading Update
26th Apr 20225:14 pmRNSHolding(s) in Company
25th Apr 20223:36 pmRNSHolding(s) in Company
20th Apr 20223:59 pmRNSDirector/PDMR Shareholding
11th Apr 202211:30 amRNSDirector/PDMR Shareholding
1st Apr 20224:00 pmRNSHolding(s) in Company
1st Apr 20227:00 amRNSNotice of AGM
31st Mar 20229:56 amRNSHolding(s) in Company
31st Mar 20229:51 amRNSHolding(s) in Company
29th Mar 20223:07 pmRNSHolding(s) in Company
29th Mar 202212:00 pmRNSEBT Purchase
29th Mar 202210:54 amRNSHolding(s) in Company
15th Mar 20227:00 amRNSRefinancing of US Private Placement Notes
10th Mar 20223:12 pmRNSDirector/PDMR Shareholding
10th Mar 20222:43 pmRNSHolding(s) in Company
8th Mar 202212:09 pmRNSHolding(s) in Company
3rd Mar 20223:21 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
22nd Feb 20224:10 pmRNSNotice of Results
25th Jan 202210:05 amRNSDirector Declaration
16th Dec 20217:00 amRNSNew Non-Executive Director
25th Nov 202112:57 pmRNSTotal Voting Rights
17th Nov 20217:00 amRNSTrading Update
28th Oct 20219:43 amRNSHolding(s) in Company
14th Sep 20217:49 amRNSHolding(s) in Company
13th Aug 202110:21 amRNSChange of Auditor
30th Jul 20213:28 pmRNSHolding(s) in Company
27th Jul 20217:00 amRNSHalf-year Report
2nd Jun 202112:06 pmRNSHolding(s) in Company
2nd Jun 202112:00 pmRNSHolding(s) in Company
1st Jun 20214:12 pmRNSHolding(s) in Company
1st Jun 20213:53 pmRNSHolding(s) in Company
25th May 20215:30 pmRNSRSA Insurance Group
24th May 20213:22 pmRNSDirector/PDMR Shareholding
20th May 20214:39 pmRNSResult of AGM
20th May 20217:00 amRNSCapital Markets Event
13th May 20214:45 pmRNSHolding(s) in Company
11th May 20214:38 pmRNSHolding(s) in Company
10th May 20214:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.